Cytologically targeted next-generation sequencing: a synergy for diagnosing urothelial carcinoma-Reference-Cited by-同舟云学术

Cytologically targeted next-generation sequencing: a synergy for diagnosing urothelial carcinoma

Published:2021-01 Issue:1 Volume:10 Page:94-102
ISSN:2213-2945
Container-title:Journal of the American Society of Cytopathology
language:en
Short-container-title:Journal of the American Society of Cytopathology

Author:

Harris Taylor^ORCID,Sheel Ankur^ORCID,Zong Yang,Hutchinson Lloyd M.,Cornejo Kristine M.^ORCID,Bubendorf Lukas^ORCID,Yates Jennifer,Fischer Andrew H.^ORCID

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference63 articles.

1. A review on the accuracy of bladder cancer detection methods;Zhu;J Cancer,2019

2. Mixed-methods approach to exploring patients' perspectives on the acceptability of a urinary biomarker test in replacing cystoscopy for bladder cancer surveillance;Tan;BJU Int,2019

3. FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy;Kompier;PLoS One,2010

4. Detection and surveillance of bladder cancer using urine tumor DNA;Dudley;Cancer Discov,2019

5. The health economics of bladder cancer: a comprehensive review of the published literature;Botteman;Pharmacoeconomics,2003

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing the Use of Next-Generation Sequencing Assays in Patients With Urothelial Carcinoma: Recommendations by the 2023 San Raffaele Retreat Panel;Clinical Genitourinary Cancer;2024-08

2. Utility and performance of cell blocks in urine cytology: Experience at three teaching hospitals;Cancer Cytopathology;2023-06-08

3. KRASMutation Analysis Using Cell-free DNA of Pancreatic Cancer;Anticancer Research;2023-05-29

4. Diagnostische und prädiktive Marker in der Harntraktzytologie;Der Pathologe;2022-02-08

5. Ancillary Studies in Urinary Cytology;The Paris System for Reporting Urinary Cytology;2022